Please try another search
MediciNova, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 1 million. Net loss was USD 8.57 million compared to USD 14.07 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.29 a year ago. Diluted loss per share from continuing operations was USD 0.17 compared to USD 0.29 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 0 | 1 | ||
Gross Profit | 0 | 1 | ||
Operating Income | -2.49 | -1.15 | -3.3 | -2.96 |
Net Income | -2.06 | -0.723 | -2.87 | -2.92 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 66.27 | 68.14 | 68.72 | 71.13 |
Total Liabilities | 3.89 | 3.47 | 3.54 | 3.41 |
Total Equity | 62.38 | 64.67 | 65.18 | 67.73 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -0.499 | -1.37 | -2.38 | -3.18 |
Cash From Investing Activities | 0 | -0.003 | -0.019 | 39.93 |
Cash From Financing Activities | ||||
Net Change in Cash | -0.508 | -1.37 | -2.38 | 36.75 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review